POZ Exclusives

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » POZ Exclusives


July 24, 2012
We Can End AIDS March Converges on White House
Coinciding with the XIX International AIDS Conference (AIDS 2012), a mass of approximately 1,000 demonstrators under the banner of the We Can End AIDS Coalition crisscrossed Washington, DC, on July 24, ultimately converging on the White House to demand major changes to domestic and international HIV policy.
July 22, 2012
John Damonti on Corporate Philanthropy
POZ Editor in Chief Regan Hofmann interviews John Damonti, President, Bristol-Myers Squibb Foundation on the role of corporate philanthropy.
Chirfi Guindo on Global Partnerships
POZ Editor in Chief Regan Hofmann talks with Chirfi Guindo, General Manager & Global Commercial Leader, HIV, Merck & Co., about global partnerships.
Daria Hazuda on Antiviral Research
POZ Editor in Chief Regan Hofmann talks with Daria Hazuda, Worldwide Head of Antiviral Basic Research, Merck & Co., about antiviral research.
Paul Schaper on Global Public Policy
POZ Editor in Chief Regan Hofmann talks with Paul Schaper, Senior Director, Global Public Policy, Merck & Co., about global public policy.
Violet Kanonuhwa on Access to Care
POZ Editor in Chief Regan Hofmann talks with Violet Kanonuhwa, Patient and Community Affairs Manager, Bristol-Myers Squibb, about access to care.
The Crisis in Access to Care
Moderated by Regan Hofmann, this roundtable discussion on the crisis in access to HIV care included Vignetta Charles, Laurie Dill, Cynthia Gomez, Kathie Hiers, David Holtgrave and David Munar.
Phangisile Mtshali on Secure the Future
POZ deputy editor Oriol Gutierrez talks with Phangisile Mtshali, director of Secure the Future at the Bristol-Myers Squibb Foundation.
July 20, 2012
Full-Court Press on HIV Criminal Laws
Scott A. Schoettes outlines the battle being waged in state courts throughout America over HIV criminalization. He discusses recent victories and current efforts to end prosecutions that single out people living with HIV for more severe charges.
July 17, 2012
PrEP Talk 101
A pill prevents getting HIV? Here’s what you need to know about Truvada, the HIV med the FDA just approved as pre-exposure prophylaxis (PrEP).
July 05, 2012
Revolutionary HIV Tests Needed at Home and Globally
Globally, more than half of the 34 million people living with HIV don’t know they have it. 
More Web Exclusives

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    guycmh328
    Columbus
    Ohio


    koffeeboss
    Tucson
    Arizona


    OahuAJ
    Turlock
    California


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.